Vertex Pharmaceuticals Incorporated Chugs Along

Vertex Pharmaceuticals Incorporated Chugs Along

Vertex Pharmaceuticals (NASDAQ: VRTX) keeps chugging along, generating increased sales for its two cystic fibrosis drugs as it gains additional approvals to treat more patients, and producing clinical trial data for its drug candidates that will hopefully be generating sales in the coming years.

Metric

Q2 2017

Continue reading

Source: Fool.com